The 35th CINP World Congress of Neuropsychopharmacology

Presentation information

[CINP2024] Short Communications

CINP2024 » Short Communications

Short Communications 6
Anxiety Disorders and Autism - Preclinical

Fri. May 24, 2024 1:30 PM - 2:45 PM Room 7 (G407)

Chair: Andrew Holmes (NIH)

[SC6-2] Antipsychotic agents in anxiety disorders: an umbrella review

*Rafael Freire1,2,3, Amir Garakani4,5, Frank Buono5, Mona Salehi6, Melissa Funaro7, Anna Klimowicz8, Harshit Sharma5, Clara Faria3, Kaitlyn Larkin9 (1. Department of Psychiatry and Centre for Neuroscience Studies, Queen's University, Kingston, Ontario, Canada, 2. Kingston General Hospital Research Institute, Kingston Health Sciences Centre, Kingston, Canada, 3. Laboratory of Panic and Respiration, Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil, 4. Department of Psychiatry and Behavioral Health, Greenwich Hospital, Greenwich, CT, United States of America, 5. Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, United States of America, 6. Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America , 7. Harvey Cushing/John Hay Whitney Medical Library, Yale University, New Haven, CT, United States of America, 8. New York University Langone Psychiatry Associates, New York, NY, United States of America, 9. Department of Psychology, Northern Illinois University, DeKalb, IL, United States of America)

Keywords:generalized anxiety disorder, social anxiety disorder, antipsychotic agents, dopamine antagonist, panic disorder

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

Password